Skip to main content

EQUETRO

NDC 30698-421 · Validus Pharmaceuticals LLC

Generic nameCarbamazepine
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength200 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryNDA

Packages

30698-421-12 — 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-421-12)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16571-682 — CARBAMAZEPINE, 16714-063 — carbamazepine, 16714-064 — carbamazepine, 16714-065 — carbamazepine, 17856-4047 — Carbamazepine, 27241-231 — Carbamazepine, 27241-232 — Carbamazepine, 27241-233 — Carbamazepine, 29300-382 — Carbamazepine, 30698-419 — Carbamazepine, 30698-423 — Carbamazepine, 35561-355 — carbamazepine, 35561-356 — carbamazepine, 35561-357 — carbamazepine, 42806-274 — Carbamazepine, 42806-275 — Carbamazepine, 42806-276 — Carbamazepine, 43063-328 — Carbamazepine, 43353-953 — CARBAMAZEPINE, 46708-420 — Carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.